NCT00410371View on ClinicalTrials.gov

Study to Compare Two Formulations of Lamotrigine in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

96

Participants

Timeline

Start Date

December 28, 2006

Primary Completion Date

January 25, 2007

Study Completion Date

January 25, 2007

Conditions

Mental Disorders

Interventions

DRUG

Lamotrigine

Lamotrigine

DRUG

GI267119

25 mg ODT

Trial Locations (1)

68502

GSK Investigational Site, Lincoln

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY